Molecules (Nov 2023)

Comparative Antibacterial and Efflux Pump Inhibitory Activity of Isolated Nerolidol, Farnesol, and α-Bisabolol Sesquiterpenes and Their Liposomal Nanoformulations

  • Jorge Ederson Gonçalves Santana,
  • Cícera Datiane de Morais Oliveira-Tintino,
  • Gabriel Gonçalves Alencar,
  • Gustavo Miguel Siqueira,
  • Daniel Sampaio Alves,
  • Talysson Felismino Moura,
  • Saulo Relison Tintino,
  • Irwin Rose Alencar de Menezes,
  • João Pedro Viana Rodrigues,
  • Vanessa Barbosa Pinheiro Gonçalves,
  • Roberto Nicolete,
  • Talha Bin Emran,
  • Clara Mariana Gonçalves Lima,
  • Sheikh F. Ahmad,
  • Henrique Douglas Melo Coutinho,
  • Teresinha Gonçalves da Silva

DOI
https://doi.org/10.3390/molecules28227649
Journal volume & issue
Vol. 28, no. 22
p. 7649

Abstract

Read online

The efflux systems are considered important mechanisms of bacterial resistance due to their ability to extrude various antibiotics. Several naturally occurring compounds, such as sesquiterpenes, have demonstrated antibacterial activity and the ability to inhibit efflux pumps in resistant strains. Therefore, the objective of this research was to analyze the antibacterial and inhibitory activity of the efflux systems NorA, Tet(K), MsrA, and MepA by sesquiterpenes nerolidol, farnesol, and α-bisabolol, used either individually or in liposomal nanoformulation, against multi-resistant Staphylococcus aureus strains. The methodology consisted of in vitro testing of the ability of sesquiterpenes to reduce the Minimum Inhibitory Concentration (MIC) and enhance the action of antibiotics and ethidium bromide (EtBr) in broth microdilution assays. The following strains were used: S. aureus 1199B carrying the NorA efflux pump, resistant to norfloxacin; IS-58 strain carrying Tet(K), resistant to tetracyclines; RN4220 carrying MsrA, conferring resistance to erythromycin. For the EtBr fluorescence measurement test, K2068 carrying MepA was used. It was observed the individual sesquiterpenes exhibited better antibacterial activity as well as efflux pump inhibition. Farnesol showed the lowest MIC of 16.5 µg/mL against the S. aureus RN4220 strain. Isolated nerolidol stood out for reducing the MIC of EtBr to 5 µg/mL in the 1199B strain, yielding better results than the positive control CCCP, indicating strong evidence of NorA inhibition. The liposome formulations did not show promising results, except for liposome/farnesol, which reduced the MIC of EtBr against 1199B and RN4220. Further research is needed to evaluate the mechanisms of action involved in the inhibition of resistance mechanisms by the tested compounds.

Keywords